Gutanga ibiyobyabwenge bigenewe Kanseri

Gutanga ibiyobyabwenge bigenewe Kanseri igamije kunoza imikorere yubuvuzi no kugabanya ingaruka mbi mugutanga imiti ivura kanseri ya kanseri, mugihe hagabanijwe guhura ningirangingo nzima. Ubu buryo bukoresha ingamba zitandukanye, zirimo nanoparticles, antibodies, na peptide, kugirango uhitemo uturemangingo twa kanseri no kurekura imiti aho ikibyimba. Uku kubyara kwibandaho byongera ibiyobyabwenge mu kibyimba, biganisha ku musaruro unoze kandi bikagabanya uburozi bwa sisitemu. Intangiriro yo Gutanga Ibiyobyabwenge Gutanga imiti ya kanseri yagiye ihinduka cyane uko imyaka yagiye ihita, kuva muri chimiotherapie gakondo kugeza muburyo bukomeye nka Gutanga ibiyobyabwenge bigenewe Kanseri. Intego y'ibanze ya Gutanga ibiyobyabwenge bigenewe Kanseri ni ukugabanya ingaruka zo kuvura ibiyobyabwenge mugihe hagabanijwe ingaruka mbi zuburozi kuri selile nzima. Ibi bigerwaho no kugeza ibiyobyabwenge kumurongo wibibyimba cyangwa kanseri ya kanseri, kureba ko ingaruka zibiyobyabwenge byibanda aho bikenewe cyane. Kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri, twiyemeje guteza imbere iki gice binyuze mubushakashatsi bushya no gukoresha amavuriro.Kuki intego yo gutanga ibiyobyabwenge ari ngombwa? Imiti gakondo ya chimiotherapie akenshi ikubiyemo imiyoborere itunganijwe yibiyobyabwenge, bivuze ko ibiyobyabwenge bizenguruka umubiri wose. Ibi birashobora gutera ingaruka zikomeye, nko guta umusatsi, isesemi, no guhagarika sisitemu yumubiri, kuko selile nzima nazo ziterwa n imiti ya chimiotherapie. Gutanga ibiyobyabwenge bigenewe Kanseri itanga ibyiza byinshi byingenzi: Kugabanya Ingaruka Zuruhande: Mu kwibasira selile ya kanseri byumwihariko, selile nzima zirokoka, biganisha ku ngaruka nke kandi nkeya. Kunoza imikorere: Umubare munini wibiyobyabwenge urashobora gutangwa muburyo bwikibyimba, bikongera imbaraga. Kongera umusaruro w'abarwayi: Gukora neza no kugabanya ingaruka mbi bishobora kuganisha ku mibereho myiza no muri rusange ku barwayi ba kanseri. Kunesha kurwanya ibiyobyabwenge: Gutanga intego birashobora gufasha kunesha uburyo bwo kurwanya ibiyobyabwenge ingirabuzimafatizo za kanseri zishobora gukura mugihe.Ingamba zo Gutanga Ibiyobyabwenge Intego Zifata ingamba zitandukanye zikoreshwa muri Gutanga ibiyobyabwenge bigenewe Kanseri, buri kimwe gifite uburyo bwihariye bwo guhitamo kanseri ya kanseri: Targeting TargetingPassive targeting ishingiye kubintu byihariye biranga ingirangingo z'ibibyimba, nk'imiyoboro y'amaraso yamenetse hamwe n'amazi ya lymphatike. Nanoparticles yashizweho kugirango ikoreshe ibyo bintu, ikusanya cyane muri microen ibidukikije. Ibi byitwa kandi Enhanced Permeability and Retention (EPR) ingaruka. Intego yibikorwa Intego yibikorwa ikubiyemo guhindura abatwara ibiyobyabwenge hamwe na ligande zihariye, nka antibodies, peptide, cyangwa aptamers, bihuza na reseptors bikabije kuri selile ya kanseri. Iyi mikoranire yorohereza gufata imiti itwara kanseri. Ubu buryo bukubiyemo: Antibody-Drug Conjugates (ADCs) ADCs igizwe na antibody imenya byimazeyo antigen ifitanye isano na kanseri, ifitanye isano nibiyobyabwenge bya cytotoxic. ADC imaze guhuza ingirangingo ya kanseri, iba imbere, kandi imiti ikarekurwa imbere mu kagari, bigatuma abantu bapfa. Urugero ni Ado-Trastuzumab Emtansine (Kadcyla) yibasira kanseri ya kanseri y'ibere ya HER2 nziza [1] .Imikoranire ya Ligand-Receptor Imikorere ya kanseri akenshi ikabya kwakirwa neza hejuru yabyo. Muguhuza ligande (molekile zihuza naba reseptors) kubatwara ibiyobyabwenge, birashoboka kwibasira ibiyobyabwenge kuri selile. Ibyakira bya folate hamwe na reseptor ya transfert ni intego rusange [2] .Simuli-Responsive DeliveryStimuli-yitabira gutanga uburyo bwo gutanga imiti igenewe kurekura ibiyobyabwenge gusa iyo bikurikiwe nimpamvu zidasanzwe ziboneka mumyanya mikorobe yibibyimba, nkimpinduka za pH, ibikorwa bya enzyme, cyangwa ubushobozi bwa redox. Ibi byemeza ko imiti irekurwa gusa kubyimba ikibyimba, bikagabanya ingaruka zitari nziza. Ingero zirimo gukoresha liposomes yunvikana ya pH irekura imitwaro yabyo mubidukikije bya aside irike yibibyimba [3] .Nanoparticles in Targeted Drug DeliveryNanoparticles igira uruhare runini muri Gutanga ibiyobyabwenge bigenewe Kanseri. Utwo duce duto, ubusanzwe turi hagati ya nanometero 1 na 100 z'ubunini, turashobora guhingurwa gutwara ibiyobyabwenge no guhitamo kubigeza kuri selile. Ubwoko butandukanye bwa nanoparticles burakoreshwa, buri kimwe ninyungu zacyo: Liposomes: Imitsi ya spherical igizwe na lipide bilayers, liposomes irashobora gukwirakwiza imiti ya hydrophilique na hydrophobique. Polymeric Nanoparticles: Byakozwe na polymers biodegradable, iyi nanoparticles itanga imiti igenzurwa kandi ikongerera umutekano. Utudomo twa Quantum: Semiconductor nanocrystal ifite imiterere yihariye ya optique, utudomo twa kwant dushobora gukoreshwa mugushushanya no gutanga ibiyobyabwenge. Carbon Nanotubes: Ibikoresho bya cilindrike bikozwe muri atome ya karubone, nanotubes ya karubone irashobora gukoreshwa hamwe na ligande hamwe nibiyobyabwenge.Urugero rwibikoresho bigamije gutanga ibiyobyabwengeSeveral Gutanga ibiyobyabwenge bigenewe Kanseri sisitemu zirimo gukoreshwa mubuvuzi cyangwa zirimo gutezwa imbere: Doxil / Caelyx: Liposomal doxorubicin, yemerewe kuvura kanseri yintanga, sarcoma ya Kaposi, na myeloma myinshi [4]. Ihindurwa rya liposomal rigabanya umutima wumutima ugereranije na doxorubicine gakondo. Abraxane: Paclitaxel ihujwe na Albumin, ikoreshwa mu kuvura kanseri y'ibere, kanseri y'ibihaha itari ntoya, na kanseri y'urwagashya [5]. Guhuza alubumu byongera ibiyobyabwenge kurubuga rwibibyimba.Ibibazo hamwe nicyerekezo kizaza Mugihe Gutanga ibiyobyabwenge bigenewe Kanseri ifite amasezerano akomeye, hasigaye ibibazo byinshi: Tumor Heterogeneity: Ingirabuzimafatizo za kanseri ziri mu kibyimba zirashobora kwerekana imiterere itandukanye, bigatuma bigorana kwibasira ingirabuzimafatizo zose neza. Kurwanya ibiyobyabwenge: Ingirabuzimafatizo za kanseri zirashobora guteza imbere imiti igamije igihe. Inzitizi zo gutanga: Kugera ahabyimba birashobora kuba ingorabahizi kubera inzitizi zifatika, nka barrière yamaraso. Kwiyongera no Gukora: Gukora sisitemu yo gutanga ibiyobyabwenge bigenewe ku rugero runini birashobora kuba ingorabahizi kandi bihenze.Ibikorwa byubushakashatsi bizaza byibanda kuri: Gutegura ingamba zihamye zo kurwanya intego yo gutsinda ibibyimba bitavutse. Guhuza imiti igamije hamwe nubundi buryo bwo kuvura, nka immunotherapy. Gushiraho uburyo bwo gutanga ibintu bushobora kubyutsa ibidukikije bihinduka. Kunoza ubunini nogukoresha neza uburyo bwo gukora ibiyobyabwenge bigamije.Uruhare rwikigo cyubushakashatsi bwa kanseri ya Shandong BaofaAt Shandong Baofa Ikigo Cyubushakashatsi Kanseri, tugira uruhare rugaragara mubushakashatsi no guteza imbere udushya Gutanga ibiyobyabwenge bigenewe Kanseri Sisitemu. Itsinda ryacu ryabahanga n’abaganga barimo gukora kugira ngo batsinde imbogamizi zavuzwe haruguru kandi bahindure ibyavuye mu bushakashatsi mu bikorwa by’ubuvuzi. Turabyizera Gutanga ibiyobyabwenge bigenewe Kanseri ni ingamba zingenzi zogutezimbere imiti ivura kanseri no kuzamura imibereho yabarwayi ba kanseri.UmwanzuroGutanga ibiyobyabwenge bigenewe Kanseri byerekana iterambere rikomeye mu kuvura kanseri, bitanga ubushobozi bwo kunoza imikorere no kugabanya ingaruka. Muguhitamo guhitamo kanseri ya kanseri, sisitemu irashobora gutanga imiti myinshi yibibanza byikibyimba, biganisha kubisubizo byiza kubarwayi. Mugihe ibibazo bikiriho, ubushakashatsi nibikorwa byiterambere biracyatanga inzira yo kuvura kanseri neza kandi yihariye Ikigo cyigihugu cya kanseri - Antibody-Ibiyobyabwenge Kwibanda kuri folate reseptor yo kuvura kanseri pH-yunvikana liposomes yo kuvura kanseri. Ikigo cy’ubuvuzi cy’i Burayi - Doxil FDA - Abraxane Prescribing Information